Design, synthesis and antihistaminic (H1) activity of some condensed 3- aminopyrimidin-4(3H)-ones

European Journal of Medicinal Chemistry

Volumn 35, Issue 3, 2000, Pages 351-358

  Shishoo, Chamanlal J ^a   Shirsath, Vikas S ^a   Rathod, Ishwarsinh S ^a   Yande, Vikas D ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

Antihistaminics; Condensed pyrimidines; H1 antagonists; Molecular modelling

Indexed keywords

3 AMINOPYRIMIDIN 4(3H) ONE DERIVATIVE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; PYRIMIDINONE DERIVATIVE; SULFONAMIDE; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPHYXIA; CONTROLLED STUDY; DRUG CONFORMATION; DRUG DESIGN; DRUG SYNTHESIS; GUINEA PIG; HISTAMINE RELEASE; MOLECULAR MODEL; NONHUMAN; SEDATION;

EID: 0034110864     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(00)00128-8     Document Type: Article

References (24)

1. Saxena A.K., Saxena M. Developments in antihistaminics (H1). Progress in Drug Research. 1992;35-126 Ernst Jucker, Basel.
2. Garrison J.C. Histamine, Bradykinine, 5-Hydroxytryptamine and their antagonists. Gilman A.G, Rall T.E, Nies A.S, Taylor P. The Pharmacological Basis of Therapeutics. 8th :1990;575 Pergamon Press, NY.
3. Green J.P., Weinstein H. Psychopharmacology: A Generation of Progress. 1978;319 Raven Press, NY.
4. Carr A.A., Mayer D.R. Arzeneim.-Forsch./Drug. Res. 32:1982;1157-1160.
5. Ahn H.S., Barnett A. Eur. J. Pharmacol. 127:1986;153-157.
6. Cooper D.G., Young R.C., Durant G.J., Ganellin C.R. Histamine receptors. Hansch C. Comprehensive Medicinal Chemistry. 1990;323 Pergamon Press, NY.
7. Bradley C.M., Nicholson A.N. Eur. J. Clin. Pharmacol. 32:1987;419-423.
8. Moraques J., Roberts D.J. Drugs Future. 15:1990;674.
9. Boehringer Ingelhiem. Drugs Future. 12:1987;1106.
10. Brown E.A., Griffiths R., Harvey G.S., Owen D.A.A. Br. J. Pharmacol. 87:1986;569-578.
11. Boera P.A., Bertolasi V., Gilli G. Arzeneim.-Forsch./Drug. Res. 36:1986;895-902.
12. Naruto S., Motoc I., Marshall G.R. Eur. J. Med. Chem. 20:1985;529-534.
13. Diurno M.V., Mazzoni O., Pescopo E., Calignano A., Giordano F., Bolognese A. J. Med. Chem. 35:1992;2910-2912.
14. TerLaak A.M., Venhort J., Kelder G.M.D., Timmerman H. J. Med. Chem. 38:1995;3351-3360.
15. Yamashita M., Ito S., Sugama K., Fukui H., Smith B., Nakanishi K., Wada H. Biochem. Biophys. Res. Commun. 177:1991;1233-1239.
16. Fujimoto K., Horio Y., Sugama K., Ito S., Liu Y.Q., Fukui H. Biochem. Biophys. Res. Commun. 190:1993;294-301.
17. De Becker M.D., Gommeren W., Moereels H., Nobels G., Gompel T.V., Leysen J.E., Luyten W.H.M.L. Biochem. Biophys. Res. Commun. 197:1993;1601-1608.
18. Traiffort E., Leurs R., Arrang J.M., Tardivel-Lacombe J., Daiaz I., Schwartz J.C., Ruat M. J. Neurochem. 62:1994;507-518.
19. Ohtak K., Hayashi H., Mizuguchi H., Kagamiyama H., Fujimoto K., Fukui H. Biochem. Biophys. Res. Commun. 203:1994;1096-1099.
20. Shishoo C.J., Shirsath V.S., Rathod I.S., Brahmbhat S.B., Pathak U.S., Jain K.S. Drug Design Discovery. 15:1997;105-115.
21. Gewald K., Schinke S., Bottchar. Chem. Ber. 99:1965;94-95.
22. CS Chem Office Pro, Version 3.1, CambridgeSoft Corporation, 875, Massachusetts Avenue, Cambridge, Massachusetts, 02139, USA.
23. Ghosh M.N. Quantitative study of the antagonist on isolated preparation. Fundamentals of Experimental Pharmacology, Second Edition, 60-63. 1984;107-118 Calcutta: Scientific Book Agency.
24. Saxena M., Agarwal S.K., Patnaik G.K., Saxena A.K. J. Med. Chem. 33:1990;2970-2976.